Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET

Thomas A. Hope

doi:10.2967/jnumed.120.257808

EditorialTheranostics

Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET

Thomas A. Hope

Journal of Nuclear Medicine December 2020, 61 (12) 1764; DOI: https://doi.org/10.2967/jnumed.120.257808

Thomas A. Hope

University of California, San Francisco, San Francisco, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 61, Issue 12

December 1, 2020

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET

Thomas A. Hope

Journal of Nuclear Medicine Dec 2020, 61 (12) 1764; DOI: 10.2967/jnumed.120.257808

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET

Thomas A. Hope

Journal of Nuclear Medicine Dec 2020, 61 (12) 1764; DOI: 10.2967/jnumed.120.257808

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
- DISCLOSURE
- REFERENCES
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Theranostics

Assessing Response to [¹⁷⁷Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
¹⁷⁷Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT

Show more Theranostics

Clinical

Treatment Monitoring of Immunotherapy and Targeted Therapy Using ¹⁸F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
Deep-Learning Generation of Synthetic Intermediate Projections Improves ¹⁷⁷Lu SPECT Images Reconstructed with Sparsely Acquired Projections
Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial

Show more Clinical

Main menu

User menu

Search

Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Clinical

Similar Articles